Background: Cardioneuroablation (CNA) is a novel procedure that shows promising results in reducing syncope recurrence in patients with refractory vasovagal syncope (VVS). However, its effectiveness and safety remain controversial.
Objective: We performed an updated meta-analysis evaluating CNA efficacy and safety in patients with refractory VVS.